AI Digital Pathology for Fibrosis in MASH and MAFLD
Refining Pathology's Lens
We unveil unprecedented insights into fibrosis on tissue biopsies using our stain-free, AI-based digital pathology platform, enabling our partners to accelerate therapeutics.
Stain-free Imaging and AI Image Analysis
Augmenting Fibrosis Analysis
Our proprietary technology integrates label-free Second Harmonic Generation imaging and explainable AI to consistently visualize and quantify subtleties within biological tissues that conventional methods miss. By analyzing key morphological and architectural markers, we provide translatable data from preclinical studies to clinical trials.
Accelerating Therapeutic Development for Fibrosis
Mining Deep Data with Digital Pathology
Our imaging and analysis services accelerate advancements and regulatory approvals across the drug development and clinical diagnostic value chain.
Preclinical to Clinical Translatability
Enhancing Clinical Trial Efficiency and Success
Clinical Diagnostics Development
Digitizing Healthcare
Through evidence-based studies, we are pushing the boundaries to algorithmize decision-making from drug development to precision diagnosis, to prediction of disease progression, and subsequently, life-changing therapies personalized to each patient. Discover how our stain-free, AI digital pathology platform can support your objectives.
